TCTR20200616004已完成不适用
Safety monitoring and primary efficacy on wound healing of Dioscorea bulbifera Linn Jell by public hospital patients for the addition into the National List of Essential Drugs.
/A0 个研究点目标入组 1,026 人开始时间: 2020年6月16日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 1,026
研究概览
简要总结
The results showed adverse drug reactions in only one patient. Importantly, wound sizes were significantly reduced. Furthermore, 99% of patients would use this drug in the future.These findings provide more evidence to support the traditional use of Dioscorea bulbifera Linn for the treatment of wounds, and this evidence could support its entry into the national list of herbal medicines in Thailand
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 70 Years（—）
- 性别
- All
入选标准
- •1.Age Minimum 18 Years : Maximum 70Years
- •2.No allergic history of herbs
- •3.Willing to participate in this research
排除标准
- •1.Wound infection
- •2.The physician agreed to leave the project for using other treatments.
研究者
相似试验
招募中
不适用
Assessment of efficacy and safety for a new wound dressing URGO 310 3166 in the local treatment of venous or mixed leg ulcers: a european, randomised clinical trialleg ulcersDRKS00009329aboratoires URGO220
已完成
3 期
Clinical Trial of wound healing solution in diabetic foot ulcerCTRI/2012/02/002415Centaur Pharmaceuticals Pvt Ltd311
已完成
不适用
Safety and Performance Evaluation of the Topical Hemostatic Device (AC5™) Following Excision of Skin LesionsSkin NeoplasmsNCT02704104Arch Therapeutics46
已完成
3 期
Single-arm study for assessment of safety and effectiveness of the ultracompact extracorporeal membrane oxygenation (ECMO) system (BR13030) use as a long-term cardiopulmonary support for severe heart and/or respiratory failure: study protocol for multiple-center, single-arm non-randomized, uncontrolled, and investigator-initiated clinical trialJPRN-UMIN000039474ational Cerebral and Cardiovascular Center25
已完成
1 期
Allogeneic ABCB5-positive Stem Cells for Treatment of CVUSkin Ulcer Venous Stasis ChronicNCT03257098RHEACELL GmbH & Co. KG31